Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Apr
23
2020
COVID-19: IP Strategies for Universities and Nonprofits During the Pandemic – Mitigating Patent Infringement Risks When Making PPE and Other Health-Related Supplies K&L Gates
May
1
2020
COVID-19: Labs Beware! – EKRA Expands DOJ’s Enforcement Arsenal in the COVID-19 Fraud Battle K&L Gates
Jun
26
2020
Market Entry and Real World Data – China’s Medical Device Industry K&L Gates
Feb
8
2024
Fraud May Not Always Unravel All–What Does the Contract Say? K&L Gates
Mar
23
2017
Medicinal Products: the EU and the US Mutually Recognize Manufacturing Standards K&L Gates
Dec
2
2020
OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees K&L Gates
Mar
23
2021
First Cannabis-Related Business SARS Penalty Against a Depository Institution K&L Gates
Jul
29
2019
The Scotch Whisky Saga: Where Name And Reputation Is Not Enough K&L Gates
Oct
23
2023
California Bans Four Federally Cleared Additives From Use in Food K&L Gates
Dec
4
2023
Brussels Regulatory Brief: November 2023 K&L Gates
Mar
13
2024
Litigation Minute: Beauty from Within and the Confusing Claims Landscape K&L Gates
Apr
15
2024
Chlormequat Contamination in Food Products Draws Attention K&L Gates
Dec
29
2020
Federal Courts Block Implementation of Most Favored Nation Drug Pricing Rule K&L Gates
May
7
2021
HHS Exemptions for Buprenorphine (But not Methadone) Prescribers K&L Gates
Mar
17
2022
COVID-19: State Law Telehealth Considerations: State Licensure Requirements Persist, Permissible Telehealth Modalities Generally Expand, and Insurance Parity Laws Ensure Reimbursement (Part 2 of a 3-Part Series) K&L Gates
Apr
18
2022
Litigation Minute: New Bioengineered Food Disclosure Rules and Litigation Risks K&L Gates
Apr
9
2019
Fashion & Food Industry Update: More Companies Adopting Blockchain Solutions K&L Gates
Aug
29
2022
Biometric Privacy Statutes and Insurance Coverage: Recent Developments in Illinois and the National Landscape K&L Gates
Sep
26
2022
Issue-Spotting Hospital Activities that May Trigger FDA Regulatory Oversight [PODCAST] K&L Gates
Jan
31
2023
Are Medical Diagnostic Methods Patent Ineligible by Convention?: CareDx, Inc. v. Natera, Inc. and Eurofins Viracor, Inc. K&L Gates
Nov
26
2019
Ferrero successfully enforces the Tic Tac shape mark in Italy K&L Gates
Nov
27
2023
Artificial Sweeter Decision Sours Halal Authority: Halal Certification Authority Pty Limited V Flujo Sanguineo Holdings Pty Limited [2023] FCAFC 175 K&L Gates
Jan
25
2024
An Overview of the US Food and Drug Administration's Legislative Goals (Part I) K&L Gates
Feb
1
2017
To the Federal Circuit, Some PTAB Petitioners Have No Appeal Whatsoever K&L Gates
Apr
12
2021
Something is Buzzing in the 9th Circuit: How Canned Tuna, Bumble Bees, and Uninjured Class Members combine for an Important Class Certification Ruling K&L Gates
Jun
16
2018
"Culvert Case" Affirmed - Potential Implications for Northwest Regulators and Private Parties K&L Gates
Nov
15
2021
Federal Circuit Further Clarifies Venue in Hatch-Waxman Cases K&L Gates
Mar
28
2022
In the Weeds: Why Arbitration May Be the Key to Preserving Enforcement of Cannabis M&A and VC Contracts K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins